The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125505673 12550567 3 F 20160302 20160821 20160712 20160823 PER US-PFIZER INC-2016326939 PFIZER 78.00 YR F Y 99.79000 KG 20160823 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125505673 12550567 1 PS LYRICA PREGABALIN 1 50 MG 2, TWICE A DAY Y 21446 100 MG CAPSULE, HARD BID
125505673 12550567 2 SS GABAPENTIN. GABAPENTIN 1 Oral 2 DF, 2X/DAY (2 TABLETS IN THE MORNING AND 2 TABLETS IN THE EVENING BY MOUTH) Y 20882 2 DF FILM-COATED TABLET BID
125505673 12550567 3 SS GABAPENTIN. GABAPENTIN 1 UNK Y 20882 FILM-COATED TABLET
125505673 12550567 4 C NORCO ACETAMINOPHENHYDROCODONE BITARTRATE 1 [HYDROCODONE 5MG]/[PARACETAMOL 325MG], AS NEEDED (5-325MG TABLET 1-2 BY MOUTH AS NEEDED) 0
125505673 12550567 5 C NORCO ACETAMINOPHENHYDROCODONE BITARTRATE 1 UNK 0
125505673 12550567 6 C BENICAR OLMESARTAN MEDOXOMIL 1 Oral 40 MG, 1X/DAY 0 40 MG QD
125505673 12550567 7 C NIFEDIPINE. NIFEDIPINE 1 Oral 60 MG, 1X/DAY, IN THE MORNING 0 60 MG TABLET QD
125505673 12550567 8 C SYNTHROID LEVOTHYROXINE SODIUM 1 Oral 75 UG, 1X/DAY 0 75 UG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125505673 12550567 1 Neuralgia
125505673 12550567 2 Neuralgia
125505673 12550567 4 Pain
125505673 12550567 6 Blood pressure abnormal
125505673 12550567 7 Blood pressure abnormal
125505673 12550567 8 Hypothyroidism

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
125505673 12550567 Gait disturbance
125505673 12550567 Musculoskeletal pain
125505673 12550567 Neuralgia
125505673 12550567 Pain
125505673 12550567 Pain in extremity
125505673 12550567 Peripheral swelling
125505673 12550567 Product use issue
125505673 12550567 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
125505673 12550567 1 20160402 20160710 0
125505673 12550567 2 20160302 20160402 0
125505673 12550567 3 20160302 20160402 0
125505673 12550567 4 20160302 20160402 0
125505673 12550567 5 20160302 20160402 0